ReShape Lifesciences Inc. Signs Material Definitive Agreement
Ticker: HIND · Form: 8-K · Filed: Jul 3, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-event
TL;DR
RESH just signed a big deal, details TBD.
AI Summary
On June 27, 2025, ReShape Lifesciences Inc. entered into a material definitive agreement. The filing does not provide specific details on the agreement's nature or any associated dollar amounts, but it indicates a significant event for the company.
Why It Matters
This filing signals a significant new development for ReShape Lifesciences Inc., potentially impacting its business operations, strategic direction, or financial standing.
Risk Assessment
Risk Level: medium — The lack of specific details in the 8-K regarding the material definitive agreement introduces uncertainty about its terms and potential impact.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- June 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 18 Technology Drive, Suite 110 Irvine, CA 92618 (address) — Address of principal executive offices
- 949-429-6680 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the material definitive agreement entered into by ReShape Lifesciences Inc. on June 27, 2025?
The filing does not specify the nature of the material definitive agreement.
Are there any financial terms or dollar amounts associated with this material definitive agreement?
The filing does not disclose any specific financial terms or dollar amounts related to the agreement.
What is the principal executive office address for ReShape Lifesciences Inc.?
The principal executive office is located at 18 Technology Drive, Suite 110 Irvine, CA 92618.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 27, 2025.
What is the SEC file number for ReShape Lifesciences Inc.?
The SEC file number is 001-37897.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding ReShape Lifesciences Inc. (HIND).